Osteoporosis Drugs Market 2021-26: Size, Share, Price, Trends and Research Report

Healthcare and Medical

According to the latest report by IMARC Group, titled “Osteoporosis Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global osteoporosis drugs market size reached a strong growth in 2020. Osteoporosis is a bone disease that causes deterioration of bone tissues and strength. It is diagnosed by performing various diagnostic procedures, such as X-ray, magnetic resonance imaging (MRI), and computed tomography (CT). At present, several drugs are available in different formulations, ranging from regular tablets to intravenous (IV) infusions, for alleviating the symptoms of osteoporosis. These drugs aid in restoring the balance of tissue formation, reducing the risk of fractures by repairing microscopic defects in bones, and improving the overall muscle strength of the patients.

Request Free Sample Report: https://www.imarcgroup.com/osteoporosis-drugs-market/requestsample

The growing prevalence of osteoporosis due to sedentary consumer lifestyles and excessive consumption of alcohol and tobacco, is propelling the demand for osteoporosis drugs. Furthermore, the increasing incidences of chronic celiac disease, renal ailments, cancer, lupus, multiple myeloma, rheumatoid arthritis, etc., are also driving the product demand. Additionally, the rising geriatric population, who are more prone to bone mass loss, is further bolstering the need for osteoporosis drugs. Besides this, extensive R&D activities for the introduction of novel therapeutics and late-stage drugs will continue to drive the global market for osteoporosis drugs in the coming years. Looking forward, IMARC Group expects the global osteoporosis drugs market to exhibit moderate growth during 2021-2026.

Breakup by Product Type:

  • Bisphosphonates
  • Calcitonin
  • Rank Ligand Inhibitor
  • Parathyroid Hormone Therapy (PTH)
  • Selective Estrogen Receptor Modulators (SERMs)
  • Sclerostin Inhibitor
  • Others

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Others

Competitive Landscape with Key Player:

  • Amgen Inc.
  • Eli Lilly and Company
  • Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Radius Health Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.

Ask Analyst for Instant Discount and Download Full Report with TOC and List of Figure: http://bit.ly/3rcEE3E

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Single User: https://www.imarcgroup.com/checkout?id=3104&method=1

Corporate User: https://www.imarcgroup.com/checkout?id=3104&method=3

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Leave a Reply

Your email address will not be published. Required fields are marked *